DPW
UTHR icon

DiNuzzo Private Wealth’s United Therapeutics UTHR Stock Holding History

DiNuzzo Private Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.5K Hold
12
– – ﹤0.01% 353
2026
Q1 		$7.12K Hold
12
– – ﹤0.01% 324
2025
Q4 		$5.85K Buy
12
+1
+9% +$466 ﹤0.01% 356
2025
Q3 		$3.35K Sell
11
-1
-8% -$336 ﹤0.01% 473
2025
Q2 		$3.45K Buy
12
+1
+9% +$299 ﹤0.01% 459
2025
Q1 		$3.39K Sell
11
-1
-8% -$343 ﹤0.01% 433
2024
Q4 		$4.24K Hold
12
– – ﹤0.01% 386
2024
Q3 		$4.3K Buy
12
+1
+9% +$338 ﹤0.01% 384
2024
Q2 		$3.5K Buy
11
+1
+10% +$265 ﹤0.01% 359
2024
Q1 		$2.3K Hold
10
– – ﹤0.01% 429
2023
Q4 		$2.2K Buy
+10
New +$2.31K ﹤0.01% 402

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

DiNuzzo Private Wealth's UTHR Position: Q2 2026 in Review

DiNuzzo Private Wealth held its United Therapeutics (UTHR) position steady in Q2 2026 at 12 shares worth $6.5K. The position accounts for ﹤0.01% of the portfolio, ranked #353.

DiNuzzo Private Wealth first reported a position in UTHR in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.12K in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • DiNuzzo Private Wealth held 12 shares of United Therapeutics worth $6.5K as of Q2 2026.
  • DiNuzzo Private Wealth left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #353 holding.
  • DiNuzzo Private Wealth first reported a position in United Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • DiNuzzo Private Wealth's United Therapeutics position peaked at $7.12K in Q1 2026.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.